opentrade on 
↗
↗event3 outcomes
When will the FDA approve Intellia Therapeutics' lonvo-z?
·Science and Technology·ends Jan 8, 2028vol cum
$3.3k
vol 24h
$3
outcomes
3
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
65¢
· 0.0pp
24h change
vol cum
$536
vol 24h
$0
spread
0.06
ends
Jan 8, 2028
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
Before 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
before 202777¢· 0.0ppbefore November69¢· 0.0ppbefore October50¢▼ 1.0pp
+3 others
$158 24h · 6 markets
polymarketFDA approves Retatrutide this year?
yes2¢· 0.0pp
$9 24h · 1 market
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢· 0.0pp
M0 24h · 1 market
kalshiWill the FDA approve VERVE-102?
Before 203582¢· 0.0ppBefore 203478¢· 0.0ppBefore 203274¢· 0.0pp
+3 others
$0 24h · 6 markets
polymarketFDA approves Daraxonrasib this year?
yes45¢▼ 1.0pp
$0 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢· 0.0pp
M0 24h · 1 market